Schmidt MA - Search Results

1

Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.

Reubi JC, Waser B, Schaer JC, Laederach U, Erion J, Srinivasan A, Schmidt MA, Bugaj JE. Reubi JC, et al. Among authors: schmidt ma. Eur J Nucl Med. 1998 May;25(5):481-90. doi: 10.1007/s002590050247. Eur J Nucl Med. 1998. PMID: 9575243

2

Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.

de Visser M, Janssen PJ, Srinivasan A, Reubi JC, Waser B, Erion JL, Schmidt MA, Krenning EP, de Jong M. de Visser M, et al. Among authors: schmidt ma. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1134-9. doi: 10.1007/s00259-003-1189-y. Epub 2003 May 24. Eur J Nucl Med Mol Imaging. 2003. PMID: 12768332

3

In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.

Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. Lewis JS, et al. Among authors: schmidt ma. Nucl Med Biol. 1999 Apr;26(3):267-73. doi: 10.1016/s0969-8051(98)00105-x. Nucl Med Biol. 1999. PMID: 10363797

4

Radiotherapeutic efficacy of (153)Sm-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats.

Bugaj JE, Erion JL, Johnson MA, Schmidt MA, Srinivasan A. Bugaj JE, et al. Among authors: schmidt ma. Nucl Med Biol. 2001 Apr;28(3):327-34. doi: 10.1016/s0969-8051(01)00197-4. Nucl Med Biol. 2001. PMID: 11323245

5

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.

Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion JL, Schmidt MA, Bugaj JL, de Jong M, Krenning EP. Kwekkeboom DJ, et al. Among authors: schmidt ma. Eur J Nucl Med. 2001 Sep;28(9):1319-25. doi: 10.1007/s002590100574. Eur J Nucl Med. 2001. PMID: 11585290

6

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.

de Visser M, Bernard HF, Erion JL, Schmidt MA, Srinivasan A, Waser B, Reubi JC, Krenning EP, de Jong M. de Visser M, et al. Among authors: schmidt ma. Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1228-38. doi: 10.1007/s00259-006-0356-3. Epub 2007 Feb 8. Eur J Nucl Med Mol Imaging. 2007. PMID: 17287960 Free article.

7

Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.

de Jong M, Bakker WH, Bernard BF, Valkema R, Kwekkeboom DJ, Reubi JC, Srinivasan A, Schmidt M, Krenning EP. de Jong M, et al. J Nucl Med. 1999 Dec;40(12):2081-7. J Nucl Med. 1999. PMID: 10616889 Free article.

8

Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.

Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL. Achilefu S, et al. Among authors: schmidt ma. J Med Chem. 2003 Jul 17;46(15):3403-11. doi: 10.1021/jm030081k. J Med Chem. 2003. PMID: 12852770

9

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

de Jong M, Breeman WA, Bakker WH, Kooij PP, Bernard BF, Hofland LJ, Visser TJ, Srinivasan A, Schmidt MA, Erion JL, Bugaj JE, Mäcke HR, Krenning EP. de Jong M, et al. Among authors: schmidt ma. Cancer Res. 1998 Feb 1;58(3):437-41. Cancer Res. 1998. PMID: 9458086

10

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.

de Jong M, Breeman WA, Bernard BF, Bakker WH, Schaar M, van Gameren A, Bugaj JE, Erion J, Schmidt M, Srinivasan A, Krenning EP. de Jong M, et al. Int J Cancer. 2001 Jun 1;92(5):628-33. doi: 10.1002/1097-0215(20010601)92:5<628::aid-ijc1244>3.0.co;2-l. Int J Cancer. 2001. PMID: 11340564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

745 results

Search Page

Filters